美国 · SEC FORM 4
Septerna, Inc.
SEPN · Nasdaq · CIK 0001984086 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
33 同一窗口内观察到的 Form 4 交易行
18 sales · 15 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-03-07 · Ezekowitz Alan · $92.3K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Shaikhly SamiraChief People Officer
○▼○▼○▼○▼
Long Daniel D.SVP, Drug Discovery
○▼○▼○▼○▼
Bhatt ElizabethPresident and COO
○▼○▼
TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwner
▼
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.Director; Director,TenPercentOwner
▼
● 买入▼ 卖出○ 其他
—
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-03-07 · Ezekowitz Alan.
近期 Form 4 活动
0买入
26卖出
20其他 Form 4 交易行
16SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出18 sale line(s) · 仅供背景
其他15 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,096,190
- 上期报告
- 2,894,002
- 日均成交量
- 351,889
- 回补天数
- 8.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-03-07 | Ezekowitz Alan | 买入 (P) | Common Stock | 13,319 | USD 6.93 | USD 92,301 | SEC 申报 ↗ |
| 2025-03-06 | Ezekowitz Alan | 买入 (P) | Common Stock | 41,355 | USD 6.00 | USD 248,130 | SEC 申报 ↗ |
| 2025-03-05 | Ezekowitz Alan | 买入 (P) | Common Stock | 37,835 | USD 5.82 | USD 220,200 | SEC 申报 ↗ |
| 2025-03-04 | Ezekowitz Alan | 买入 (P) | Common Stock | 7,491 | USD 6.35 | USD 47,568 | SEC 申报 ↗ |
| 2025-02-27 | Labrucherie Gil M | 买入 (P) | Common Stock | 3,718 | USD 5.85 | USD 21,750 | SEC 申报 ↗ |
| 2025-02-27 | Finer Jeffrey | 买入 (P) | Common Stock | 3,000 | USD 5.80 | USD 17,400 | SEC 申报 ↗ |
| 2025-02-26 | Finer Jeffrey | 买入 (P) | Common Stock | 4,000 | USD 5.70 | USD 22,800 | SEC 申报 ↗ |
| 2025-02-25 | Labrucherie Gil M | 买入 (P) | Common Stock | 6,282 | USD 5.59 | USD 35,116 | SEC 申报 ↗ |
| 2025-02-25 | Finer Jeffrey | 买入 (P) | Common Stock | 10,000 | USD 5.68 | USD 56,800 | SEC 申报 ↗ |
| 2025-02-24 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 买入 (P) | Common Stock | 18,861 | USD 6.00 | USD 113,166 | SEC 申报 ↗ |
| 2025-02-21 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 买入 (P) | Common Stock | 427,668 | USD 5.94 | USD 2,540,348 | SEC 申报 ↗ |
| 2025-02-21 | Labrucherie Gil M | 买入 (P) | Common Stock | 5,000 | USD 5.85 | USD 29,250 | SEC 申报 ↗ |
| 2025-02-20 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 买入 (P) | Common Stock | 612,674 | USD 5.92 | USD 3,627,030 | SEC 申报 ↗ |
| 2025-02-20 | Labrucherie Gil M | 买入 (P) | Common Stock | 14,500 | USD 5.88 | USD 85,260 | SEC 申报 ↗ |
| 2025-02-19 | Labrucherie Gil M | 买入 (P) | Common Stock | 10,500 | USD 5.51 | USD 57,855 | SEC 申报 ↗ |
Form 4 申报证据
46 transaction lines in the latest 365-day window; 74 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Long Daniel D. | 卖出 (S) | Common Stock | 3,333 | USD 37.83 | USD 126,087 | SEC 申报 ↗ |
| 2026-09-01 | Long Daniel D. | 期权行权／转换 (M) | Common Stock | 3,333 | USD 2.76 | USD 9,199 | SEC 申报 ↗ |
| 2026-08-12 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 147,200 | USD 50.27 | USD 7,399,858 | SEC 申报 ↗ |
展开近期 Form 4 证据 (29 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Long Daniel D. | 卖出 (S) | Common Stock | 3,333 | USD 37.83 | USD 126,087 | SEC 申报 ↗ |
| 2026-09-01 | Long Daniel D. | 期权行权／转换 (M) | Common Stock | 3,333 | USD 2.76 | USD 9,199 | SEC 申报 ↗ |
| 2026-08-12 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 147,200 | USD 50.27 | USD 7,399,858 | SEC 申报 ↗ |
| 2026-08-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 卖出 (S) | Common Stock | 746,500 | USD 42.50 | USD 31,726,250 | SEC 申报 ↗ |
| 2026-08-11 | Bhatt Elizabeth | 卖出 (S) | Common Stock | 25,000 | USD 44.00 | USD 1,100,000 | SEC 申报 ↗ |
| 2026-08-11 | Bhatt Elizabeth | 期权行权／转换 (M) | Common Stock | 25,000 | USD 5.79 | USD 144,658 | SEC 申报 ↗ |
| 2026-08-03 | Long Daniel D. | 卖出 (S) | Common Stock | 3,334 | USD 34.47 | USD 114,923 | SEC 申报 ↗ |
| 2026-08-03 | Long Daniel D. | 期权行权／转换 (M) | Common Stock | 3,334 | USD 2.76 | USD 9,202 | SEC 申报 ↗ |
| 2026-07-15 | Bhatt Elizabeth | 卖出 (S) | Common Stock | 4,000 | USD 33.99 | USD 135,960 | SEC 申报 ↗ |
| 2026-07-15 | Bhatt Elizabeth | 期权行权／转换 (M) | Common Stock | 4,000 | USD 6.81 | USD 27,240 | SEC 申报 ↗ |
| 2026-07-01 | Long Daniel D. | 卖出 (S) | Common Stock | 3,333 | USD 34.36 | USD 114,531 | SEC 申报 ↗ |
| 2026-07-01 | Long Daniel D. | 期权行权／转换 (M) | Common Stock | 3,333 | USD 2.76 | USD 9,199 | SEC 申报 ↗ |
| 2026-06-29 | Shaikhly Samira | 卖出 (S) | Common Stock | 2,178 | USD 35.18 | USD 76,622 | SEC 申报 ↗ |
| 2026-06-29 | Shaikhly Samira | 期权行权／转换 (M) | Common Stock | 2,178 | USD 6.81 | USD 14,832 | SEC 申报 ↗ |
| 2026-06-22 | Long Daniel D. | 卖出 (S) | Common Stock | 15,000 | USD 35.51 | USD 532,590 | SEC 申报 ↗ |
| 2026-06-22 | Long Daniel D. | 期权行权／转换 (M) | Common Stock | 15,000 | USD 5.42 | USD 81,371 | SEC 申报 ↗ |
| 2026-06-12 | Shaikhly Samira | 卖出 (S) | Common Stock | 6,250 | USD 35.08 | USD 219,250 | SEC 申报 ↗ |
| 2026-06-12 | Shaikhly Samira | 期权行权／转换 (M) | Common Stock | 6,250 | USD 11.70 | USD 73,125 | SEC 申报 ↗ |
| 2026-06-01 | Shaikhly Samira | 卖出 (S) | Common Stock | 5,935 | USD 28.92 | USD 171,665 | SEC 申报 ↗ |
| 2026-06-01 | Shaikhly Samira | 期权行权／转换 (M) | Common Stock | 5,935 | USD 1.87 | USD 11,111 | SEC 申报 ↗ |
| 2026-05-26 | Shaikhly Samira | 卖出 (S) | Common Stock | 11,798 | USD 30.06 | USD 354,648 | SEC 申报 ↗ |
| 2026-05-26 | Shaikhly Samira | 期权行权／转换 (M) | Common Stock | 11,798 | USD 6.81 | USD 80,344 | SEC 申报 ↗ |
| 2026-04-15 | Bhatt Elizabeth | 卖出 (S) | Common Stock | 4,000 | USD 24.34 | USD 97,354 | SEC 申报 ↗ |
| 2026-04-15 | Bhatt Elizabeth | 期权行权／转换 (M) | Common Stock | 4,000 | USD 6.81 | USD 27,240 | SEC 申报 ↗ |
| 2026-03-02 | Shaikhly Samira | 卖出 (S) | Common Stock | 70,453 | USD 28.10 | USD 1,979,971 | SEC 申报 ↗ |
| 2026-03-02 | Shaikhly Samira | 期权行权／转换 (M) | Common Stock | 70,453 | USD 1.84 | USD 129,456 | SEC 申报 ↗ |
| 2026-02-18 | Bhatt Elizabeth | 卖出 (S) | Common Stock | 4,000 | USD 28.96 | USD 115,856 | SEC 申报 ↗ |
| 2026-02-18 | Bhatt Elizabeth | 期权行权／转换 (M) | Common Stock | 4,000 | USD 6.81 | USD 27,240 | SEC 申报 ↗ |
| 2025-11-10 | Long Daniel D. | 卖出 (S) | Common Stock | 3,501 | USD 18.06 | USD 63,228 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SEPN |
| CIK | 0001984086 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 74 transaction lines from 2024-10-28 to 2026-09-01 19 P purchase lines · 26 S sale lines · 29 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.